Educational conferences through the Division of Urology at the University of Colorado School of Medicine (UCSOM) are accredited through the UCSOM Office of Continuing Medical Education. The UCSOM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Colorado Denver School of Medicine designates Urology Conferences as certified for AMA PRA Category 1 Credit(s)TM. (Physicians should only claim credit commensurate with the extent of their participation in the activity.)
Urology Grand Rounds are held on Monday mornings. Beginning at 7:00 we join the Department of Surgery for Grand Rounds in the AIP2 Conference Center Auditorium. At 8:00 a.m. we break out into Urology Specific Grand Rounds. The Urology Specific Grand Rounds will usually be held in Room A of the AIP2 Conference Center. Occassionally, however, the conference will be held in a different location. Please check the conference schedule below for specific information. Click for a map of the campus and parking areas.
The Urology Didactic Conference Schedule is available by clicking on the link below:
2013 -2014 Urology Conference Schedule
Physicians who are interested in attending a conference(s), should register for individual sessions by clicking on the “Register Now” button below or by calling the UCSOM Division of Urology at 303-724-2712.
Participants are required to sign an attendance sheet for each conference he/she attends in order to receive CME credit. Certificates of CME credit are available at the end of each academic year by submitting a completed CME Credit Request form and specified fee. Click for a copy of the CME Credit Request Form.
February 7th, 2014 - Pediatric Urology Visiting Professor
The Division of Urology is very pleased to announce Dr. Christopher Cooper from the Department of Urology at the University of Iowa as our latest Visiting Professor.
Dr. Cooper's research focuses on the etiology, diagnosis and treatment of fetal genitourinary anomalies and pediatric voiding dysfunction. Recently, Dr. Cooper's research studies have concentrated on the treatment decision-making process in children with vesicoureteral reflux (VUR). VUR is the retrograde flow of urine from the bladder into the ureter, due to incompetence of the vesicoureteral valve (between the bladder and the ureter), which can lead to bacterial infection in the kidney. Because severe VUR (high grade), if left untreated, can lead to kidney damage, and mild (low grade) VUR may spontaneously resolve, parents and clinicians face a dilemma in determining which treatment, if any, is best for each child. Treatment may range from antibiotic prophylaxis to surgical intervention. Because surgery carries an inherent risk in any child, and long-term antibiotic use is debatable, careful consideration of all variables in each case of VUR must be considered. To further the understanding of VUR and which children are likely to benefit from various forms of intervention, Dr. Cooper and colleagues are actively investigating factors which may determine whether spontaneous resolution without sequelae is likely, or if intervention is warranted. Age, gender, grade of reflux, laterality, renal scarring, cause of reflux, as well as more complex factors such as bladder volume and pressure at onset of reflux, and bladder and bowel function, are all taken into account. Dr. Cooper and coworkers have analyzed these aspects and reported numerous findings, including the creation of a computational model to predict VUR outcome. Other aspects of Dr. Cooper's ongoing clinical research include prenatal hydronephrosis, including participation in an international database, overactive bladder, and reconstructive genitourinary surgery.
In addition, a Journal Club Conference led by Dr. Cooper will be held. Articles from the conference can be found here.